Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Chan

Showing results (151-160 of 263) with videos related to

Pageof 27
Sort By:
Neurobiology of Aging|December 3, 2025
Time-restricted feeding rescues sociability deficits and reduces neuroinflammation in aged miceLouise M Ince, Brandy N Routh, Jeffrey S Darling, et al.
Investigational New Drugs|October 10, 2017
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trialDana B Cardin, Laura W Goff, Emily Chan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2022
p53 null phenotype is a "positive result" in urothelial carcinoma in situAnkur R Sangoi, Emily Chan, Eman Abdulfatah, et al.
JCO Precision Oncology|April 16, 2025
Testing and Interpretation of Human Epidermal Growth Factor Receptor 2 Protein Expression and <i>ERBB2</i> Gene Amplification in Advanced Urothelial CarcinomaVadim S Koshkin, Johanna M Schafer, Emilie Scherrer, et al.
Artificial Organs|April 11, 2014
An integrated array of microfluidic oxygenators as a neonatal lung assist device: in vitro characterization and in vivo demonstrationNiels Rochow, Asmaa Manan, Wen-I Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2014
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumorsIgor Puzanov, Colin R Lindsay, Laura Goff, et al.
American Journal of Clinical Pathology|June 13, 2025
Urothelial carcinoma with osteoclast-like giant cells: An expanded immunohistochemical and molecular profileCarol N Rizkalla, Maria Tretiakova, Carlos J Suarez, et al.
Histopathology|October 31, 2025
Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrenceNancy Y Greenland, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
The American Journal of Surgical Pathology|September 17, 2019
A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 PatientsHubert D Lau, Emily Chan, Alice C Fan, et al.
Cancer Medicine|February 28, 2014
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancerDana B Cardin, Laura Goff, Chung-I Li, et al.
Pageof 27

Showing results (151-160 of 263) with videos related to

Sort By:
Pageof 27
Neurobiology of Aging|December 3, 2025
Time-restricted feeding rescues sociability deficits and reduces neuroinflammation in aged miceLouise M Ince, Brandy N Routh, Jeffrey S Darling, et al.
Investigational New Drugs|October 10, 2017
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trialDana B Cardin, Laura W Goff, Emily Chan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2022
p53 null phenotype is a "positive result" in urothelial carcinoma in situAnkur R Sangoi, Emily Chan, Eman Abdulfatah, et al.
JCO Precision Oncology|April 16, 2025
Testing and Interpretation of Human Epidermal Growth Factor Receptor 2 Protein Expression and <i>ERBB2</i> Gene Amplification in Advanced Urothelial CarcinomaVadim S Koshkin, Johanna M Schafer, Emilie Scherrer, et al.
Artificial Organs|April 11, 2014
An integrated array of microfluidic oxygenators as a neonatal lung assist device: in vitro characterization and in vivo demonstrationNiels Rochow, Asmaa Manan, Wen-I Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2014
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumorsIgor Puzanov, Colin R Lindsay, Laura Goff, et al.
American Journal of Clinical Pathology|June 13, 2025
Urothelial carcinoma with osteoclast-like giant cells: An expanded immunohistochemical and molecular profileCarol N Rizkalla, Maria Tretiakova, Carlos J Suarez, et al.
Histopathology|October 31, 2025
Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrenceNancy Y Greenland, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
The American Journal of Surgical Pathology|September 17, 2019
A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 PatientsHubert D Lau, Emily Chan, Alice C Fan, et al.
Cancer Medicine|February 28, 2014
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancerDana B Cardin, Laura Goff, Chung-I Li, et al.
Pageof 27